BDX vs INTS
Becton Dickinson and Company (BDX) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
INTS does not have a complete income-statement cache yet.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. INTS currently screens at market cap $7.7M.
Not investment advice. Open the BDX and INTS stock pages for the full models.
Not investment advice.